Suppr超能文献

在用人的微量长期骨髓培养物进行的体外造血过程中,补充了同种异体、T细胞去除的同种异体或同基因骨髓细胞。

In vitro hemopoiesis in human micro long-term bone marrow cultures recharged with either allogeneic, T-cell-depleted allogeneic, or syngeneic bone marrow cells.

作者信息

Mergenthaler H G, Dörmer P

机构信息

GSF-Institut für Experimentelle Hämatologie, München, Federal Republic of Germany.

出版信息

Blut. 1990 Apr;60(4):228-32. doi: 10.1007/BF01728789.

Abstract

The production of granulocyte-macrophage colony-forming cells (GM-CFC) and the proliferation period in human long-term bone marrow cultures are inferior to murine cultures. There is also evidence that recharge of the cultures after establishing confluent stromal layers will not greatly improve myelopoiesis. Data in the literature indicate that PHA-responsive T lymphocytes persist for up to 5 weeks in human but not in murine long-term marrow cultures. We therefore analyzed the effects of recharging micro long-term bone marrow cultures with bone marrow cell samples depleted by T lymphocytes. Depletion was performed in a complement-mediated cytotoxicity assay by applying the monoclonal antibody CAMPATH-1. Our data show that regardless of whether T cells were removed only at recharge, at both initiation and recharge, or only at initiation, obvious enhancement could neither be achieved in the GM-CFC production nor in the proliferation period. Furthermore, no advantage was seen when using syngeneic marrow cells. We conclude that in allogeneic long-term marrow cultures hemopoiesis is not limited by immunological incompatibilities.

摘要

人长期骨髓培养中粒细胞 - 巨噬细胞集落形成细胞(GM - CFC)的产生及增殖期均不如鼠类培养。也有证据表明,在建立汇合的基质层后对培养物进行再接种并不能显著改善骨髓生成。文献数据表明,PHA反应性T淋巴细胞在人长期骨髓培养中可持续长达5周,而在鼠类长期骨髓培养中则不然。因此,我们分析了用T淋巴细胞耗竭的骨髓细胞样本对微型长期骨髓培养物进行再接种的效果。通过应用单克隆抗体CAMPATH - 1在补体介导的细胞毒性试验中进行耗竭。我们的数据表明,无论T细胞是仅在再接种时去除、在起始和再接种时均去除,还是仅在起始时去除,在GM - CFC产生或增殖期均无法实现明显增强。此外,使用同基因骨髓细胞也未见优势。我们得出结论,在异基因长期骨髓培养中,造血不受免疫不相容性的限制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验